Invasive Aspergillosis Completed Phase 4 Trials for Caspofungin (DB00520)

IndicationStatusPhase
DBCOND0031838 (Invasive Aspergillosis)Completed4
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00334412COMBISTRAT: AmBisome® in Combination With Caspofungin for the Treatment of Invasive AspergillosisTreatment